PATENT CLAIM ANALYSIS

Application Number: 15761983
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "450000"]

Abstract:
There are provided, inter alia, methods and compositions for diagnosis and treatment of acute myeloid leukemia (AML), secondary acute myeloid leukemia (sAML), and age-related diseases.

Claim (Index 46):
A method of correcting human stem cell function in an aged microenvironment, the method comprising increasing production of one or more proteins encoded by the RNA in Table 15B in bone marrow stromal cells; and optionally further administering an effective amount of a splicing modulator to the aged microenvironment.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14342384', '12837409', '14236118', '11528890', '13739788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7646690932370809
- 35 USC 102 Novelty (BERT): 0.5149941848511485
- Combined Prediction Score: 0.7397016023984877
- Mean Citation Score: 266.791298
- Max Citation Score: 290.01474
- Similarity Product: 191.60007463555087

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test